Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience

Nivolumab is an effective and safe treatment in HCC.

Detalles Bibliográficos
Autores principales: Al jarroudi, Ouissam, Chaabouni, Hamed, Ulusakarya, Ayhan, Almohamad, Wathek, Gumus, Yusuf, Goldschmidt, Emma, Afqir, Said, Morère, Jean‐francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077298/
https://www.ncbi.nlm.nih.gov/pubmed/33936657
http://dx.doi.org/10.1002/ccr3.3970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077298/
https://www.ncbi.nlm.nih.gov/pubmed/33936657
http://dx.doi.org/10.1002/ccr3.3970

Ejemplares similares